검색어 : 통합검색[Chase Nicholas]
총 543건 중 543건 출력
, 46/55 페이지
-
451
- Prior and concurrent use of abiraterone and enzalutamide with Ra-223 in an expanded access setting.
- Sartor, A. Oliver; Fernandez, Daniel Celestino; Morris, Michael J.; Iagaru, Andrei; Brown, Alan; Almeida, Fabio; Sweeney, Christopher; Smith, Matthew Raymond; Dicker, Adam; Wong, Yu-Ning; Shore, Neal D.; Gratt, Jeremy; Petrenciuc, Oana; Vogelzang, Nicholas J.; Tulane Cancer Center, New Orleans, LA; Moffitt Cancer Center, Tampa, FL; Memorial Sloan Kettering Cancer Center, New York, NY; Stanford University, Stanford, CA; 21st Century Oncology, Fort Myers, FL; Arizona Molecular Imaging Center, Phoenix, AZ; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; Thomas Jefferson University, Philadelphia, PA; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA; Carolina Urologic Research Center, Myrtle Beach, SC; Bayer HealthCare, Whippany, NJ; Bayer HealthCare, Whippany, NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.253-253)
-
452
- Radium-223 dichloride (Ra-223) in U.S. expanded access program (EAP).
- Vogelzang, Nicholas J.; Fernandez, Daniel Celestino; Morris, Michael J.; Iagaru, Andrei; Brown, Alan; Almeida, Fabio; Sweeney, Christopher; Smith, Matthew Raymond; Dicker, Adam; Wong, Yu-Ning; Shore, Neal D.; Bangerter, Keith; Petrenciuc, Oana; Sartor, A. Oliver; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Moffitt Cancer Center, Tampa, FL; Memorial Sloan Kettering Cancer Center, New York, NY; Stanford University, Stanford, CA; 21st Century Oncology, Fort Myers, FL; Arizona Molecular Imaging Center, Phoenix, AZ; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; Thomas Jefferson University, Philadelphia, PA; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA; Carolina Urologic Research Center, Myrtle Beach, SC; Bayer HealthCare, Whippany, NJ; Bayer HealthCare, Whippany, NJ; Tulane Cancer Center, New Orleans, LA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.247-247)
-
453
- Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients
- Levin-Epstein, Rebecca; Cook, Ryan R.; Wong, J. Karen; Stock, Richard G.; Jeffrey Demanes, D.; Collins, Sean P.; Aghdam, Nima; Suy, Simeng; Mantz, Constantine; Katz, Alan J.; Nickols, Nicholas G.; Miszczyk, Leszek; Napieralska, Aleksandra; Namysl-Kaletka, Agnieszka; Prionas, Nicholas D.; Bagshaw, Hilary; Buyyounouski, Mark K.; Cao, Minsong; Mahal, Brandon A.; Shabsovich, David; Dang, Audrey; Yuan, Ye; Rettig, Matthew B.; Chang, Albert J.; Jackson, William C.; Spratt, Daniel E.; Lehrer, Eric J.; Zaorsky, Nicholas G.; Kupelian, Patrick A.; Steinberg, Michael L.; Horwitz, Eric M.; Jiang, Naomi Y.; Kishan, Amar U.; Department of Radiation Oncology, University of California Los Angeles; Department of Radiation Oncology, University of California Los Angeles; Department of Radiation Oncology, Fox Chase Cancer Center; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai; Department of Radiation Oncology, University of California Los Angeles; Department of Radiation Medicine, Georgetown University Hospital; Department of Radiation Medicine, Georgetown University Hospital; Department of Radiation Medicine, Georgetown University Hospital; 21st Century Oncology, Inc.; FROS Radiation Oncology and Cyberknife Center; Department of Radiation Oncology, Un; (Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, v.151, 2020, pp.26-32)
-
454
- Abstract 242: Bone-derived Stem Cells Repair The Heart After Myocardial Infarction Through Transdifferentiation And Paracrine Signaling Mechanisms
- Duran, Jason M; Makarewich, Catherine A; Sharp, Thomas E; Starosta, Timothy; Zhu, Fang; Hoffman, Nicholas E; Chiba, Yumi; Husain, Sharmeen; Muniswamy, Madesh; Berretta, Remus M; Kubo, Hajime; Houser, Steven R; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Fox Chase Cancer Cntr, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; Temple Univsersity Sch of Medicine, Philadelphia, PA; (Circulation research : a journal of the American Heart Association, v.113, 2013, )
-
455
- Nomogram to estimate the activity of second-line therapy for advanced urothelial carcinoma (UC).
- Sonpavde, Guru; Pond, Gregory Russell; Agarwal, Neeraj; Choueiri, Toni K.; Qu, Angela Q.; Fougeray, Ronan; Salhi, Yacine; Vaughn, David J.; James, Nicholas David; Niegisch, Guenter; Albers, Peter; Galsky, Matt D.; Wong, Yu-Ning; Stadler, Walter Michael; O'Donnell, Peter H.; Vogelzang, Nicholas J.; Sridhar, Srikala S.; Ko, Yoo-Joung; Sternberg, Cora N.; Bellmunt, Joaquim; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; McMaster University, Hamilton, ON, Canada; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Dana-Farber Cancer Institute, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Institut de Recherche Pierre Fabre, Boulogne, France; Institut de Recherche Pierre Fabre, Boulogne, France; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; University of Birmingham, Birmingham, United Kingdom; Department of Urology, Heinrich-Heine-University, Duesseldorf, Germany; Department of Urology, Heinrich-Heine-University, Duesseldorf, Germany; The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY; Fox Chase Cancer Center, Philadelphia, PA; The University of Chicago, Chicago, IL; The University of Chicago, Chicago, IL; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centr; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.31, 2013, pp.4524-4524)
-
456
- Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-<I>jun</I> antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype
- Pan, Bin; Yao, Kang-Shen; Monia, Brett P.; Dean, Nicholas M.; McKay, Robert A.; Hamilton, Thomas C.; O’ Dwyer, Peter J.; ; (Biochemical pharmacology, v.63, 2002, pp.1699-1707)
-
457
- A phase II biomarker assessment of tivozanib in oncology (BATON) trial in patients (pts) with advanced renal cell carcinoma (RCC).
- Hutson, Thomas E.; Rathmell, Kimryn; Hudes, Gary R.; Kabbinavar, Fairooz; Vogelzang, Nicholas J.; Knox, Jennifer J.; Cowey, C. Lance; Cho, Daniel C.; Choueiri, Toni K.; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX; Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC; Fox Chase Cancer Center, Philadelphia, PA; Institute of Urologic Oncology, University of California, Los Angeles, Los Angeles, CA; Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV; University Health Network, Toronto, ON, Canada; Texas Oncology-Baylor Charles A. Sammons Cancer Center and US Oncology Research, Dallas, TX; Beth Israel Deaconess Hospital, Boston, MA; Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.30, 2012, pp.TPS4686-TPS4686)
-
458
- Ra-223 experience in pretreated patients: EAP setting.
- Sartor, A. Oliver; Fernandez, Daniel Celestino; Morris, Michael J.; Iagaru, Andrei; Brown, Alan; Almeida, Fabio; Sweeney, Christopher; Smith, Matthew Raymond; Dicker, Adam; Wong, Yu-Ning; Shore, Neal D.; Gratt, Jeremy; Petrenciuc, Oana; Germino, Joseph; Vogelzang, Nicholas J.; Tulane Cancer Center, New Orleans, LA; H. Lee Moffitt Cancer Center, Tampa, FL; Memorial Sloan Kettering Cancer Center, New York, NY; Stanford University, Stanford, CA; 21st Century Oncology, Fort Myers, FL; Arizona Molecular Imaging Center, Phoenix, AZ; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; The Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA; Carolina Urologic Research Center, Myrtle Beach, SC; Bayer HealthCare, Whippany, NJ; Bayer HealthCare, Whippany, NJ; Bayer HealthCare, Whippany, NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.5063-5063)
-
459
- Paradoxical anxiolytic effect of the ‘bath salt’ synthetic cathinone MDPV during early abstinence is inhibited by a chemokine CXCR4 or CCR5 receptor antagonist
- Simmons, Steven J.; Oliver, Chicora F.; McCloskey, Nicholas S.; Reitz, Allen B.; Nayak, Sunil U.; Watson, Mia N.; Rawls, Scott M.; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University; Nathan S. Kline Institute for Psychiatric Research; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University; Fox Chase Chemical Diversity Center Inc.; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University; (Drug and alcohol dependence, v.230, 2022, pp.109204)
-
460
- A Paradigm Shift from Anatomic to Functional and Molecular Imaging in the Detection of Recurrent Prostate Cancer
- Zaorsky, Nicholas G; Yamoah, Kosj; Thakur, Madhukar L; Trabulsi, Edouard J; Showalter, Timothy N; Hurwitz, Mark D; Dicker, Adam P; Den, Robert B; Department of Radiation Oncology,Fox Chase Cancer Center, PA, USA; Department of Radiation Oncology,Jefferson Medical College of Thomas Jefferson University, PA, USA; Department of Radiology,Jefferson Medical College of Thomas Jefferson University, PA, USA; Department of Urology,Jefferson Medical College of Thomas Jefferson University, PA, USA; Department of Radiation Oncology,University of Virginia, Charlottesville, PA, USA; Department of Radiation Oncology,Jefferson Medical College of Thomas Jefferson University, PA, USA; Department of Radiation Oncology,Jefferson Medical College of Thomas Jefferson University, PA, USA; Department of Radiation Oncology,Jefferson Medical College of Thomas Jefferson University, PA, USA; (Future oncology, v.10, 2014, pp.457-474)
QUICK MENU
